Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl A, Holmdahl R
Department of Neurology, Huddinge University Hospital, Karolinska Institute, Sweden.
J Immunol. 1994 Oct 1;153(7):3337-44.
Experimental autoimmune encephalomyelitis (EAE) is influenced by polymorphism of the MHC. We have previously found that Lewis rats with certain MHC haplotypes are susceptible to disease induced with the myelin basic protein (MBP) peptide 63-88, whereas Lewis rats with other MHC haplotypes are resistant. Interestingly, rats with the MHC u haplotype develop an immune response to the MBP 63-88, but do not get EAE. In this study we have used intra-MHC recombinant rat strains to compare the influences of the MHC u with the a haplotype. We discovered the following: 1) The class II region of the MHC a haplotype permits EAE and a Th1 type of immune response as measured by IFN-gamma production after in vitro challenge of in vivo-primed T cells with MBP 63-88. 2) The class II region of the u haplotype is associated with a disease-protective immune response characterized by production of not only IFN-gamma, but also of IL-4 mRNA expression by the MBP 63-88-activated cells. 3) The class I region upstream of the class II region of the u haplotype is associated with a disease-protective effect and the expression of mRNA for TGF-beta after MBP 63-88-induced activation. Thus, such a TGF-beta response occurs in all strains expressing the class I Au allele. Treatment with Abs to CD8+ cells abrogates peptide-induced TGF-beta mRNA expression, and aggravates disease in strains with the class I Au allele.
实验性自身免疫性脑脊髓炎(EAE)受主要组织相容性复合体(MHC)多态性的影响。我们之前发现,具有某些MHC单倍型的Lewis大鼠易患由髓鞘碱性蛋白(MBP)肽63 - 88诱导的疾病,而具有其他MHC单倍型的Lewis大鼠则具有抗性。有趣的是,具有MHC u单倍型的大鼠对MBP 63 - 88产生免疫反应,但不会患上EAE。在本研究中,我们使用了MHC内重组大鼠品系来比较MHC u单倍型与a单倍型的影响。我们发现如下:1)MHC a单倍型的II类区域允许EAE以及通过用MBP 63 - 88对体内致敏的T细胞进行体外刺激后产生的IFN-γ来衡量的Th1型免疫反应。2)u单倍型的II类区域与一种疾病保护性免疫反应相关,其特征是MBP 63 - 88激活的细胞不仅产生IFN-γ,还产生IL-4 mRNA表达。3)u单倍型II类区域上游的I类区域与疾病保护作用以及MBP 63 - 88诱导激活后TGF-β mRNA的表达相关。因此,这种TGF-β反应发生在所有表达I类Au等位基因的品系中。用抗CD8 +细胞的抗体进行治疗可消除肽诱导的TGF-β mRNA表达,并加重具有I类Au等位基因的品系中的疾病。